A randomized clinical trial investigated the effects of Mindfulness-Oriented Recovery Enhancement (MORE) therapy alongside medication treatment for opioid use disorder. **Eighty-six participants** receiving methadone or buprenorphine were assigned to eight weeks of MORE or psychoeducational supportive therapy.
fMRI Findings and Brain Activity Changes
Functional magnetic resonance imaging (fMRI) was used to examine brain responses. The study found that MORE led to changes in brain activity, specifically in the lateral and ventromedial prefrontal cortices, when participants regulated responses to drug-related images. These changes were associated with reduced opioid cravings. Participants receiving MORE showed less drug-related activity in the lateral prefrontal cortex and greater activity in the ventromedial prefrontal cortex while savoring positive experiences. The study, the first to use fMRI to examine MORE’s impact, revealed that synchronized activity in the medial prefrontal cortex was reduced in the MORE group when viewing drug-related scenes.